NemaLife Launches BioSēq™ to Advance Functional Ingredient Discovery

NemaLife Inc., a pioneer in AI-driven discovery platforms, has unveiled BioSēq™, a next-generation transcriptomics tool that maps the molecular effects of nutritional bioactives to human health outcomes. This launch builds on the success of the Discovery Flywheel™, NemaLife’s 6-in-1 in vivo platform for rapid bioactive validation.

Powered by the C. elegans model—sharing up to 80% genetic similarity with humans—BioSēq™ delivers deep mechanistic insights into gene expression and signaling pathways. Together with the Discovery Flywheel™, it offers a powerful, end-to-end solution for identifying and validating bioactives across key health areas including gut health, cognitive performance, and longevity.

Learn more